AntherA.com
About AntherA.com
Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases, including cardiovascular and autoimmune diseases. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as coronary artery disease.